Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches.
OBJECTIVE
To evaluate the coverage and compliance of the Human Papilloma Virus (HPV) vaccine in Paris.


METHODS
We selected a female population living in Paris, between the ages of 14 and 23 years (French recommendations) on December 31st, 2008, that was affiliated to social security (n = 77,744). We evaluated the dynamic of HPV vaccine dose reimbursement between July 2007 and April/May 2009 for this population.


RESULTS
The coverage rate in the study population with at least one dose of the vaccine was 17%. A complete vaccination scheme (three doses) was observed in less than 43% of affiliates, whereas two doses have been reimbursed to 26% of the affiliates and only one dose to 31%. Higher rates of coverage and compliance were observed among girls between 15 and 17 years of age.


CONCLUSIONS
Coverage and compliance rates corresponding to the French HPV vaccine program appear to be lower than those observed in countries with different recommendations and implementation strategies, and particularly school-based program. Our study suggests that health authorities should modify current recommendations.
Rouzier
Roman
R
Department of Obstetrics and Gynecology, Hôpital Tenon, APHP, Paris, France. roman.rouzier@tnn.aphp.fr
Giordanella
Jean-Pierre
JP
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D005260:Female; D019538:Health Care Surveys / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D017589:Immunization Programs / Q000379:methods* / Q000706:statistics & numerical data*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D010297:Paris; D010349:Patient Compliance / Q000706:statistics & numerical data*; D055815:Young Adult
D053918:Papillomavirus Vaccines